2010
DOI: 10.1016/j.ymgme.2010.06.016
|View full text |Cite
|
Sign up to set email alerts
|

A Japanese child with asymptomatic elevation of serum creatine kinase shows PTRF-CAVIN mutation matching with congenital generalized lipodystrophy type 4

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
27
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(30 citation statements)
references
References 29 publications
3
27
0
Order By: Relevance
“…For example, as mentioned above, deficiency in Cav1 protein leads to severe and generalized lipodystrophy (Cao et al, 2008;Kim et al, 2008), whereas mutations in Cav3 lead to the development of several different muscle disease conditions (for a review, see Gazzerro et al, 2010). Cavin-1 mutations are associated with both lipodystrophy and muscle disease (Dwianingsih et al, 2010;Hayashi et al, 2009;Rajab et al, 2010) in agreement with the proposed role of cavin-1 in regulating caveola formation in both muscle and non-muscle tissues. Although the table in the accompanying poster highlights the dystrophic phenotypes directly associated with caveolins and cavin-1 inherited mutations in patients, it should be noted that malfunctioning or changes in the expression levels of these proteins have also been associated with a variety of other diseases both in vitro and in mice models (for a review see Mercier et al, 2009).…”
Section: Perspectivessupporting
confidence: 65%
See 1 more Smart Citation
“…For example, as mentioned above, deficiency in Cav1 protein leads to severe and generalized lipodystrophy (Cao et al, 2008;Kim et al, 2008), whereas mutations in Cav3 lead to the development of several different muscle disease conditions (for a review, see Gazzerro et al, 2010). Cavin-1 mutations are associated with both lipodystrophy and muscle disease (Dwianingsih et al, 2010;Hayashi et al, 2009;Rajab et al, 2010) in agreement with the proposed role of cavin-1 in regulating caveola formation in both muscle and non-muscle tissues. Although the table in the accompanying poster highlights the dystrophic phenotypes directly associated with caveolins and cavin-1 inherited mutations in patients, it should be noted that malfunctioning or changes in the expression levels of these proteins have also been associated with a variety of other diseases both in vitro and in mice models (for a review see Mercier et al, 2009).…”
Section: Perspectivessupporting
confidence: 65%
“…In these models, caveolin exhibits an increased mobility and is associated with a flat plasma membrane . In addition, the loss of caveolae caused by the lack of cavin-1 was associated with degradation of caveolin and with lipid and muscle disorders (Dwianingsih et al, 2010;Hayashi et al, 2009;Hill et al, 2008;Rajab et al, 2010).…”
Section: The Role Of the Cavin Proteins In Caveola Formation And Funcmentioning
confidence: 99%
“…For example, deficiency of Cavin-1 in skeletal muscle has been associated with human lipodystrophy, muscular dystrophy and cardiac dysfunction. [79][80][81][82][83][84] In accordance, mice lacking Cavin-1 exhibit a lipodystrophic phenotype 48 as well as an altered metabolic flux among multiple tissues, which suggests a role of Cavin-1 in the coordination of peripheral glucose and fatty-acid storage and utilization. 85 Figure 8 Analysis of the anchorage-independent cell growth in engineered RD cells.…”
Section: Discussionmentioning
confidence: 76%
“…Cavin-1-defi cient patients have a secondary defi ciency of caveolin-1 in adipocytes and therefore present a similar pattern of generalized lipodystrophy with bone marrow preservation, although they retain some mechanical adipose tissue and have vestigial dorsal subcutaneous fat. In addition, cavin-1-defi cient patients manifest features of muscular dystrophy, impaired bone formation, smooth-muscle hypertrophy, and occasional cardiac arrhythmia; this phenotype is probably due to secondary defi ciency of muscle-specifi c caveolin-3 and a more global defect in caveolae ( 24,(30)(31)(32).…”
Section: Neurological Seipinopathiesmentioning
confidence: 99%